Types of Scientific Research: Experimental, Observational, and More

Scientific research is not a single method but a family of approaches, each suited to different questions, constraints, and levels of certainty. The main categories — experimental, observational, descriptive, correlational, and review-based — differ fundamentally in how investigators interact with their subject matter and what conclusions they can legitimately draw. Knowing which type of research generated a finding is essential for reading any study critically, whether the source is a clinical trial, a survey, or a meta-analysis. These distinctions are foundational to how science works as a conceptual system.

Definition and scope

At the broadest level, scientific research is a structured process of generating knowledge through systematic inquiry. The National Institutes of Health (NIH) classifies research into two primary modes: basic research, which pursues fundamental understanding without immediate application, and applied research, which targets specific practical problems. Cutting across both modes are the methodological types that define how data are collected and analyzed.

The five major types addressed here represent the dominant frameworks across the natural and social sciences:

1. Experimental research — the investigator manipulates one or more independent variables and measures effects on a dependent variable, typically with random assignment to conditions.
2. Observational research — phenomena are recorded as they occur naturally, without intervention; this family includes cohort studies, case-control studies, and cross-sectional surveys.
3. Descriptive research — documents the characteristics of a phenomenon, population, or case without testing hypotheses about cause.
4. Correlational research — examines statistical relationships between variables without establishing causal directionality.
5. Review-based research — synthesizes existing studies, ranging from narrative literature reviews to quantitative meta-analyses that pool effect sizes across dozens or hundreds of primary studies.

Each type occupies a position on what epidemiologists call the hierarchy of evidence, with randomized controlled trials (RCTs) and meta-analyses of RCTs generally placed at the top (Oxford Centre for Evidence-Based Medicine, 2011 Levels of Evidence).

How it works

Experimental research operates through controlled manipulation. A researcher identifies an independent variable, assigns participants or units to treatment and control conditions — ideally at random — and measures outcomes. Randomization is the critical mechanism: it distributes unmeasured confounders across groups, making any observed difference attributable to the manipulation with calculable confidence. The landmark 1948 streptomycin trial conducted by the British Medical Research Council is widely recognized as the first properly randomized clinical trial, establishing the template still in use.

Observational studies forgo manipulation but use design strategies to approximate causal inference. A prospective cohort study, such as the Framingham Heart Study launched in 1948 by the U.S. Public Health Service, follows a defined population forward in time, recording exposures and outcomes as they occur naturally. Retrospective case-control studies work backwards: they identify people with an outcome and compare their past exposures to those without it. Cross-sectional studies capture a snapshot at a single point in time — useful for prevalence estimates, limited for causal claims.

Meta-analyses pool quantitative results from multiple independent studies, increasing statistical power and stability of effect estimates. The Cochrane Collaboration, established in 1993, maintains the largest curated database of systematic reviews in health care, with more than 8,000 published reviews as of its most recent annual report.

Common scenarios

Different research questions naturally map to different designs:

• A pharmaceutical company testing whether a new antihypertensive drug reduces blood pressure more than a placebo runs a double-blind RCT — the gold standard for intervention efficacy.
• An epidemiologist asking whether long-term air pollution exposure is associated with lung cancer uses a prospective cohort design, because randomly assigning people to breathe polluted air is ethically impermissible.
• A public health agency estimating what percentage of adults in a county meet physical activity guidelines uses a cross-sectional survey — fast, inexpensive, and appropriate for prevalence, not causation.
• A psychologist mapping the relationship between sleep duration and academic performance in college students runs a correlational study, producing a correlation coefficient that quantifies association without implying direction.
• A policy body evaluating whether school nutrition interventions improve child health outcomes commissions a systematic review and meta-analysis to synthesize the accumulated trial literature rather than relying on any single study.

The science methodology resources on this site explore specific design mechanics in greater depth.

Decision boundaries

Choosing a research type is not merely a procedural preference — it determines the logical ceiling on what conclusions are defensible. The core decision boundary is causal vs. associative inference.

Only experimental designs with random assignment can support causal claims in the strongest logical sense. Observational designs can support causal arguments when bolstered by Bradford Hill criteria — a set of 9 considerations including strength of association, dose-response relationship, and biological plausibility — but those arguments remain probabilistic rather than definitive (Hill, 1965, Proceedings of the Royal Society of Medicine).

A second boundary involves feasibility and ethics. Roughly half of important public health questions involve exposures that cannot be experimentally assigned to humans, pushing researchers toward observational designs regardless of their preference for experimental certainty.

A third boundary is cost and time. A large RCT running 5 years at 40 clinical sites may cost upward of $100 million (NIH National Cancer Institute trial cost estimates). A cross-sectional survey of equivalent sample size might cost 1 to 2 percent of that figure, making it the only viable option when resources are constrained.

The broader scientific process described in the site index situates these research types within the larger cycle of hypothesis generation, data collection, peer review, and replication that constitutes scientific knowledge-building.